Opdivo (nivolumab)

pCPA File Number: 20879

Negotiation Status:

Concluded with an LOI

Indication(s):

Metastatic Melanoma

Sponsor/Manufacturer:

Bristol Myers Squibb Canada Inc.

CDA-AMC Project Number:

PC0063-000

pCPA Engagement Letter Issued:

2016-05-04

Negotiation Process Concluded:

2017-01-20